Effectiveness of ECMO treatment for acute respiratory distress syndrome of patients with covid-19
a literature review
DOI:
https://doi.org/10.56102/afmo.2024.323Keywords:
Covid-19, Extracorporeal membrane oxygenation, ECMO, Respiratory failure, Therapeutic supportAbstract
Introduction: The highly virulent SARS-CoV-2 virus spread worldwide between 2020 and 2022, causing the covid-19 pandemic. The characteristics of easy transmission, difficulty to control, and severe respiratory conditions led to social isolation and the use of FFP2 masks, with hospitalizations and high mortality. Treatments such as medications, patient pronation, and invasive treatments, such as mechanical ventilation, were used to prevent the irreversibility. However, extracorporeal membrane oxygenation (ECMO) was a viable alternative for eligible patients who were unresponsive to conventional treatments. Objective: This study aimed to discuss the effectiveness of the ECMO treatment during the covid-19 pandemic. Methodology: Among the studies published between 2019 and 2023 and retrieved from databases (Google Scholar, SciELO, and PubMed), 21 met the inclusion criteria. Final considerations: The ECMO treatment demonstrated potential to contribute to the recovery of patients with severe respiratory failure despite its risks and the need for a trained multidisciplinary team combined with 24-hour care and monitoring, being an alternative to inefficient conventional treatments.
References
Silva JH da, Oliveira EC de, Hattori TY, Lemos ERS de, Terças-Trettel ACP. Descrição de um cluster da COVID-19: o isolamento e a testagem em assintomáticos como estratégias de prevenção da disseminação local em Mato Grosso, 2020. Epidemiol Serv Saúde [Internet]. 2020;29(4):e2020264. Available from: https://doi.org/10.5123/S1679-49742020000400005
Bezerra V de L, dos Anjos TB, de Souza LES, dos Anjos TB, Vidal AM, Júnior AA da S. SARSCoV-2 como agente causador da COVID-19: Epidemiologia, características genéticas, manifestações clínicas, diagnóstico e possíveis tratamentos / SARS-CoV-2 as the causative agent of COVID-19: Epidemiology, genetic characteristics, clinical manifestations, diagnosis and possible treatments. Braz. J. Hea. Rev. [Internet]. 2020 Jul. 17 [cited 2024 Nov. 21];3(4):8452-67. Available from: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/13364
Uzunian A. Coronavirus SARS-CoV-2 and Covid-19. J Bras Patol Med Lab [Internet]. 2020;56:e3472020. Available from: https://doi.org/10.5935/1676-2444.20200053
Brito SBP, Braga IO, Moraes MM, Cunha CC, Leão SC, Takenami I. Immunopathological mechanisms involved in SARS-CoV-2 infection. J Bras Patol Med Lab [Internet]. 2020;56:e3352020. Available from: https://doi.org/10.5935/1676-2444.20200056
Iser BPM, Sliva I, Raymundo VT, Poleto MB, Schuelter-Trevisol F, Bobinski F. Definição de caso suspeito da COVID-19: uma revisão narrativa dos sinais e sintomas mais frequentes entre os casos confirmados. Epidemiol Serv Saúde [Internet]. 2020;29(3):e2020233. Available from: https://doi.org/10.5123/S1679-49742020000300018
Xavier LL, Neves PFR, Paz LV, Neves LT, Bagatini PB, Timmers LFSM, Rasia-Filho AA, Mestriner RG, Wieck A. Does Angiotensin II Peak in Response to SARS-CoV-2? Front Immunol. 2021 Jan 14;11:577875. doi: https://doi.org/10.3389/fimmu.2020.577875
Brasil. Ministério da Saúde. Secretaria de Atenção Primária à Saúde (SAPS). Protocolo de Manejo Clínico do Coronavírus (COVID-19) na Atenção Primária À Saúde. v.6. Brasília (DF): 2020. Disponível em: https://egestorab.saude.gov.br/image/?file=20200327_N_01ProtocoloManejover0620200327l_4724439690741830970.pdf
Souza IV, Scodro RBL, Siqueira VLD, Cardoso RF, Caleffi-Ferracioli KR. Comorbidities and Deaths by COVID-19 in Brazil. Uningá Journal, v. 58, eUJ4054, 2021. https://www.doi.org/10.46311/2318-0579.58.eUJ4054
Bastos LS, Niquini RP, Lana RM, Villela DAM, Cruz OG, Coelho FC, Codeço CT, Gomes MFC. COVID-19 and hospitalizations for SARI in Brazil: a comparison up to the 12th epidemiological week of 2020. Cadernos de Saúde Pública 2020; 36(4):e00070120 doi: https://www.doi.org/10.1590/0102-311x00070120
De Carvalho LC, Campos GM, Pimenta IM, Vieira ARF, Nunes BCM, Lopes JPC, et al. Evidence on the effectiveness of ECMO in adults hospitalized with COVID-19. Brazilian Journal of Surgery & Clinical Research, 2021, Vol 35, Issue 2, p16. [Internet]. Disponível em: https://www.mastereditora.com.br/periodico/20210711_102511.pdf
Chaves RC de F, Rabello R, Timenetsky KT, Moreira FT, Vilanova LC da S, Bravim B de A, et al.. Oxigenação por membrana extracorpórea: revisão da literatura. Rev bras ter intensiva [Internet]. 2019Jul;31(3):410–24. Available from: https://doi.org/10.5935/0103-507X.20190063
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. BOLETIM EPIDEMIOLÓGICO ESPECIAL: COVID-19. Semana Epidemiológica 52. Versão 1. Rio de Janeiro: 2023. Disponível em: https://www.gov.br/Boletim_COVID_146_6jan23_voc_v1b%20.pdf
Falavigna M, Stein C, Amaral JLGD, Azevedo LCP, Belli KC, Colpani V, Cunha CAD, Dal-Piz zol F, Dias MBS, Ferreira JC, Freitas APDR, Gräf DD, Guimarães HP, Lobo SMA, Monteiro JT, Nunes MS, Oliveira MS, Prado CCL, Santos VCC, Silva RMD, Sobreira ML, Veiga VC, Vidal ÁT, Xavier RM, Zavascki AP, Machado FR, Carvalho CRR. Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia. Rev Bras Ter Intensiva. 2022 Jan-Mar;34(1):1-12. doi: https://www.doi.org/ 10.5935/0103-507X.20220001-en
Barbosa LD, Zanatta G, Campiolo EL. O uso de ventiladores na pandemia do COVID-19 The use of ventilators in COVID-19 pandemic Uso de ventiladores na pandemia. Interam J Med Health 2020;3:e202003052. DOI: https://doi.org/10.31005/iajmh.v3i0.141
Bastos GAN, Azambuja AZ de, Polanczyk CA, Gräf DD, Zorzo IW, Maccari JG, et al.. Características clínicas e preditores de ventilação mecânica em pacientes com COVID-19 hospitalizados no sul do país. Rev bras ter intensiva [Internet]. 2020Oct;32(4):487–92. Available from: https://doi.org/10.5935/0103-507X.20200082
Campos AFS, Alvarenga AG, E Silva GG de S, Franco GM, Azevedo IMDM. Uso da pronação consciente no manejo respiratório de pacientes com COVID 19: uma revisão literária / Use of conscious pronation in the respiratory management of patients with COVID 19: a literature review. Braz J Hea Ver [Internet]. 2022;5(3):10361–71. Disponível em: http://dx.doi.org/10.34119/bjhrv5n3-202
Battaglini D, Pelosi P, Rocco PRM. Prone positioning in COVID-19 ARDS: more pros than cons. J bras pneumol [Internet]. 2022;48(2):e20220065. Available from: https://doi.org/10.36416/1806-3756/e20220065
DellaVolpe J, Barbaro RP, Cannon JW, Fan E, Greene WR, Gunnerson KJ, et al. Joint Society of Critical Care Medicine-Extracorporeal Life Support Organization Task Force position paper on the role of the intensivist in the initiation and management of extracorporeal membrane oxygenation. Crit Care Med [Internet]. 2020;48(6):838–46. Disponível em: http://dx.doi.org/10.1097/ccm.0000000000004330
Mássimo EAL, Rodrigues ICF, Fantini MPR, Salomão JAL. ECMO use in COVID-19: Case report of a venovenous ECMO in an adult patient with COVID-19. Enfermagem Revista. 2021;(2):73–80. [Internet]. Disponível em: https://periodicos.pucminas.br/index.php/enfermagemrevista/article/view/27656/18982
la Guerra JMG, Valencia JEL, la Peña IGM, Rodríguez ET, Acero MTG, Martín RD. En busca de la monitorización ideal de heparina en soporte circulatorio mecânico. [Internet]. 2023. Disponível em: https://www.aep.es/fotos/0bb4aec1710521c12ee76289d944081716152798911.pdf
Oliveira S, Moura A, Oliveira K, Oliveira N, Silveira M. SUPORTE RESPIRATÓRIO EXTRACORPÓREO EM PACIENTES. EnciBio [Internet]. 30º de março de 2020;17(31). Disponível em: https://conhecer.org.br/ojs/index.php/biosfera/article/view/93
Lavezzo SZ, Beltrame SE, Ribeiro CHMA, Prete ACL. Effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in critically patients with COVID-19 . RSD [Internet]. 2022 Feb.12 ;11(3):e5911326388. Available from: https://rsdjournal.org/index.php/rsd/article/view/26388 . DOI: https://doi.org/10.33448/rsd-v11i3.26388
Extracorporeal Life Support Organization-ECMO, ECLS. COVID-19 Registry dashboard [Internet]. Elso.org. 2023. Disponível em: https://www.elso.org/registry/fullcovid19registrydashboard.aspxgoHash=1&sO=1&all=false&NA=false&Eur=false&Asia=-false&La=true&Africa=false&AA=false&Neo=false&Ped=false&Adlt=true&AllDts=true&YTD=f
Extracorporeal Life Support Organization-ECMO, ECLS. Extracorporeal life support organization – ECMO and ECLS [Internet]. Elso.org. 2020. Disponível em: https://www.elso.org/portals/0/files/guideline/elso_covid-19.
Saueressig MG, Mondadori DC, Miranda RCK, Schwartz P. ECMO in adults with respiratory failure [Internet] [citado 18 de julho de 2023]. Disponível em: http://www.sopterj.com.br/wp-content/uploads/2021/12/revista-pulmao-rj-vol30-n1-2021-art10.pdf
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Dexametasona para tratamento de pacientes com COVID-19. Brasília: 2021. Disponível em: https://www.gov.br/saude/pt-br/assuntos/covid-19/notas-tecnicas/2022/nota-tecnica-dexametasona.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Leticia Serbosa Reis, Milena Pacheco Villarinho, Rafaella de Carvalho Cardoso
This work is licensed under a Creative Commons Attribution 4.0 International License.
Esta licença permite que outros distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que creditem a revista pela criação original.
